| Would you like to help in some research on the regulation of what future AI-driven nanomedicines should look like? If so, researchers at the University of Bristol are looking for volunteers to discuss ethical and regulatory issues of using AI driven cancer therapies with swarm behaviour through a series of interviews. | |
| The research is part of the SWARM study – Small robots With collective behaviour as AI-driven cancer therapies; building Regulations for future nanoMedicines. | |
| The researchers are looking for: | |
|
|
| Volunteers must be over the age of 18 years old to take part. We would love to hear from you. You can find out more about the study on our SWARM study webpage or by contacting Matimba Swana at matimba.swana@bristol.ac.uk. | |
| If you would like to take part please complete this Expression of Interest Form. | |
About the SWARM study |
| Cancer occurs when abnormal cells divide in an uncontrolled way. Many cancers can be cured. But in some people cancer can return. Cancer drugs, such as chemotherapy, need to be able to kill all the cancer cells, but this means they can also kill healthy cells. | |
| Nanomedicine is the medical application of nanotechnology which works on tiny scales called ‘nanometres’ (one-billionth of a metre). Nanoparticles are nanosized particles that can assist the delivery of chemotherapy drugs to cancer cells. Scientists and Engineers can use simulations for selecting nanoparticles so drugs can more effectively reach the tumour while avoiding side effects. | |
| Nanoswarms | |
| Using simulations, scientists and engineers are working on adding swarm behaviour (present in social animals such as birds, ants, fish and termites) to nanoparticles and tiny robots (nanobots). Nanoswarms are multiple nanoparticles or nanobots that can interact with each other or their environment to achieve a task (e.g. deliver chemotherapy to a tumour without killing healthy cells), exhibiting collective behaviour inspired by swarm behaviour. | |
| SWARM study – aim & research question | |
| This project is investigating the ethics and regulations of the first in-human clinical trial of nanoswarms. We will be using interviews initially and focus groups in the next phase to explore the attitudes of stakeholders towards this swarm technology in healthcare, combined with ethical/legal analysis to consider how swarm medicine should be regulated in clinical trials. | |
| The aim is to explore how nanoswarm medicine should be regulated once this technology is available for first-in human clinical trials. | |
| Researchers | |
| This study is being organised by Matimba Swana, PhD student in the Trustworthy Autonomous Systems in Functionality Node and Academic Supervisors; Dr. Sabine Hauert, Reader (Associate Professor) in Swarm Engineering and Prof. Jonathan Ives, Professor of Empirical Bioethics & Deputy Director of Centre for Ethics in Medicine. | |
Would you like to participate? |
|
| If you are aged 18 or over, we would love to hear from you. For the interviews we are looking for oncology healthcare professionals or oncology patients or those working in drug delivery regulation or in nanomedicine research. You do not need to have any previous knowledge of nanoswarms to participate as we will show you case studies to introduce you to the technologies. | |
| Your contribution would be very helpful! For more details please contact Matimba Swana at matimba.swana@bristol.ac.uk OR complete this Expression of Interest form for interviews. | |
| We are still in the first phase of this study, so will not start interviews until later in the year, but please complete the Expression of Interest form for interviews and we will be in touch to schedule an interview. We will start recruiting for focus groups in early 2023. | |
Five fun facts |
|
|
|
| The SWARM study is part of a larger UKRI-funded PhD which is part of the Trustworthy Autonomous Systems Node in Functionality research programme, which is a multidisciplinary collaboration between ethicists, sociologists, computer scientists and engineers working together to produce guidelines for the development of trustworthy autonomous systems with evolving functionality. | |
Research Ethics Approval |
|
| This project has been reviewed and approved by the University of Bristol Faculty of Engineering Research Ethics Committee (Ref: 11141). | |
| Find out more before participating from these PDFs: | |
| SWARM study summary | |
| SWARM flyer Interviews | |
| Participant Information Sheet for Interviews | |
| SWARM flyer focus groups | |
| Participant Information for Focus Groups (will be live once interviews are completed) | |
| Expression of Interest for Focus Groups (will be live once interviews are completed) |
News
Current Heart Health Guidelines Are Failing To Catch a Deadly Genetic Killer
New research reveals that standard screening misses most people with a common inherited cholesterol disorder. A Mayo Clinic study reports that current genetic screening guidelines overlook most people who have familial hypercholesterolemia, an inherited disorder that [...]
Scientists Identify the Evolutionary “Purpose” of Consciousness
Summary: Researchers at Ruhr University Bochum explore why consciousness evolved and why different species developed it in distinct ways. By comparing humans with birds, they show that complex awareness may arise through different neural architectures yet [...]
Novel mRNA therapy curbs antibiotic-resistant infections in preclinical lung models
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria. The findings, published in Nature Biotechnology, show that in [...]
New skin-permeable polymer delivers insulin without needles
A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily injections. A recent study published in the journal Nature examines [...]
Multifunctional Nanogels: A Breakthrough in Antibacterial Strategies
Antibiotic resistance is a growing concern - from human health to crop survival. A new study successfully uses nanogels to target and almost entirely inhibit the bacteria P. Aeruginosa. Recently published in Angewandte Chemie, the study [...]
Nanoflowers rejuvenate old and damaged human cells by replacing their mitochondria
Biomedical researchers at Texas A&M University may have discovered a way to stop or even reverse the decline of cellular energy production—a finding that could have revolutionary effects across medicine. Dr. Akhilesh K. Gaharwar [...]
The Stunning New Push to Protect the Invisible 99% of Life
Scientists worldwide have joined forces to build the first-ever roadmap for conserving Earth’s vast invisible majority—microbes. Their new IUCN Specialist Group reframes conservation by elevating microbial life to the same urgency as plants and [...]
Scientists Find a Way to Help the Brain Clear Alzheimer’s Plaques Naturally
Scientists have discovered that the brain may have a built-in way to fight Alzheimer’s. By activating a protein called Sox9, researchers were able to switch on star-shaped brain cells known as astrocytes and turn them into [...]
Vision can be rebooted in adults with amblyopia, study suggests
Temporarily anesthetizing the retina briefly reverts the activity of the visual system to that observed in early development and enables growth of responses to the amblyopic eye, new research shows. In the common vision [...]
Ultrasound-activated Nanoparticles Kill Liver Cancer and Activate Immune System
A new ultrasound-guided nanotherapy wipes out liver tumors while training the immune system to keep them from coming back. The study, published in Nano Today, introduces a biodegradable nanoparticle system that combines sonodynamic therapy and cell [...]
Magnetic nanoparticles that successfully navigate complex blood vessels may be ready for clinical trials
Every year, 12 million people worldwide suffer a stroke; many die or are permanently impaired. Currently, drugs are administered to dissolve the thrombus that blocks the blood vessel. These drugs spread throughout the entire [...]
Reviving Exhausted T Cells Sparks Powerful Cancer Tumor Elimination
Scientists have discovered how tumors secretly drain the energy from T cells—the immune system’s main cancer fighters—and how blocking that process can bring them back to life. The team found that cancer cells use [...]
Very low LDL-cholesterol correlates to fewer heart problems after stroke
Brigham and Women's Hospital's TIMI Study Group reports that in patients with prior ischemic stroke, very low achieved LDL-cholesterol correlated with fewer major adverse cardiovascular events and fewer recurrent strokes, without an apparent increase [...]
“Great Unified Microscope” Reveals Hidden Micro and Nano Worlds Inside Living Cells
University of Tokyo researchers have created a powerful new microscope that captures both forward- and back-scattered light at once, letting scientists see everything from large cell structures to tiny nanoscale particles in a single shot. Researchers [...]
Breakthrough Alzheimer’s Drug Has a Hidden Problem
Researchers in Japan found that although the Alzheimer’s drug lecanemab successfully removes amyloid plaques from the brain, it does not restore the brain’s waste-clearing system within the first few months of treatment. The study suggests that [...]
Concerning New Research Reveals Colon Cancer Is Skyrocketing in Adults Under 50
Colorectal cancer is striking younger adults at alarming rates, driven by lifestyle and genetic factors. Colorectal cancer (CRC) develops when abnormal cells grow uncontrollably in the colon or rectum, forming tumors that can eventually [...]
